Putnam Investments’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $2.68M | Buy |
+534,201
| New | +$2.68M | ﹤0.01% | 688 |
|
|
2023
Q1 | – | Sell |
-171,939
| Closed | -$872K | – | 1172 |
|
|
2022
Q4 | $872K | Sell |
171,939
-92
| -0.1% | -$466 | ﹤0.01% | 855 |
|
|
2022
Q3 | $855K | Sell |
172,031
-3,119
| -2% | -$15.5K | ﹤0.01% | 878 |
|
|
2022
Q2 | $651K | Sell |
175,150
-2,176
| -1% | -$8.09K | ﹤0.01% | 907 |
|
|
2022
Q1 | $995K | Buy |
177,326
+88,028
| +99% | +$494K | ﹤0.01% | 902 |
|
|
2021
Q4 | $543K | Buy |
+89,298
| New | +$543K | ﹤0.01% | 955 |
|